[HTML][HTML] Copy number variations in pancreatic cancer: from biological significance to clinical utility

DJA Oketch, M Giulietti, F Piva - International Journal of Molecular …, 2023 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer,
characterized by high tumor heterogeneity and a poor prognosis. Inter-and intra-tumoral …

Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling

F Novelli, Y Yoshikawa, VAM Vitto, L Modesti… - Proceedings of the …, 2024 - pnas.org
We report that~ 1.8% of all mesothelioma patients and 4.9% of those younger than 55, carry
rare germline variants of the BRCA1 associated RING domain 1 (BARD1) gene that were …

Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing

K Agiannitopoulos, K Potska, A Katseli, C Ntogka… - Cancers, 2023 - mdpi.com
Simple Summary The aim of this study was to explore the utility of cascade family testing
(CFT) in families of breast cancer patients who carry specific genetic variations. We …

The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory

N Tsoulos, K Agiannitopoulos, K Potska… - Cancer Genomics & …, 2024 - cgp.iiarjournals.org
Background/Aim: The application of next-generation sequencing (NGS) technology in the
genetic investigation of hereditary cancer is important for clinical surveillance, therapeutic …

Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer

E Fountzilas, K Papadopoulou, T Chatzikonstantinou… - Cancers, 2023 - mdpi.com
Simple Summary In patients with epithelial ovarian cancer, the gold standard Myriad
MyChoice® CDx assay is used to assess homologous recombination deficiency (HRD), as a …

[HTML][HTML] Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation

N Tsoulos, E Papadopoulou, K Agiannitopoulos… - Diagnostics, 2024 - mdpi.com
Breast cancer (BC) is the most prominent tumor type among women, accounting for 32% of
newly diagnosed cancer cases. BC risk factors include inherited germline pathogenic gene …

[PDF][PDF] 拷贝数变异在卵巢癌中的研究进展.

孙梦娜, 徐盈, 任晨璐, 闫雨帆, 陈志浩… - Journal of New Medicine, 2024 - xinyixue.cn
遗传变异是导致癌症发生和发展的重要因素之一. 拷贝数变异是遗传多样性的重要来源,
在结构上表现为基因的扩增或缺失, 与肿瘤的发生和发展有关. 采用高通量测序和基因芯片技术 …

[PDF][PDF] Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing. Cancers 2023, 15, 5218. h ps

K Agiannitopoulos, K Potska, A Katseli… - doi. org/10.3390 …, 2023 - genekor.com
Background: Hereditary cancer predisposition syndromes are responsible for approximately
5–10% of all diagnosed cancer cases. In order to identify individuals at risk in a costefficient …

Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer Patients

K Potska, A Katseli, K Agiannitopoulos, C Ntogka… - 2024 - preprints.org
Pancreatic cancer stands out as one of the most lethal forms of malignancies, representing
2% of all cancer cases and contributing to 5% of cancer-related fatalities. Therefore, early …

[PDF][PDF] GENE VARIANT MAPPING IN 7,587 INDIVIDUALS REFFERED FOR HEREDITARY CANCER.

Κ Agiannitopoulos, Κ Potska, Ν Katseli, C Ntogka… - genekor.com
Methods In total, 7,787 individuals were referred for multi gene genetic testing, in the period
2020-2023, to the Genekor laboratory and genetic testing using NGS was performed (Figure …